Molecular sleuthing: unmasking hidden lymphomas through plasma DNA sequencing.
Simple blood tests may spot lymphomas months earlier than traditional biopsies, offering patients faster pathways to diagnosis.
Plasma cfDNA sequencing detected diffuse large B-cell lymphoma months before conventional biopsy in two challenging cases. This highlights cfDNA's potential as a non-invasive early diagnostic tool for occult lymphomas.
What the study was
- Study design
- Case series with molecular validation
- Population
- Adults with suspected occult lymphoma
- Sample size
- 2
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Journal of Medical Genetics
Why it surfaced
Novel application of cfDNA for early, non-invasive lymphoma detection months before biopsy — directly relevant to liquid biopsy and early cancer detection watchlist. Small case series limits design quality score.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.